Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction

Biochemical and Biophysical Research Communications

Volumn 309, Issue 1, 2003, Pages 232-240

  Ishii, Genichiro ^a   Sangai, Takafumi ^a   Oda, Tatsuya ^a   Aoyagi, Yasuyuki ^a   Hasebe, Takahiro ^a   Kanomata, Naoki ^a   Endoh, Yasushi ^a   Okumura, Chie ^a   Okuhara, Yoko ^a   Magae, Junji ^b   Emura, Makito ^c   Ochiya, Takahiro ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b INSTITUTE OF RESEARCH AND INNOVATION   (Japan)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bone marrow derived; Cancer induced stroma; Desmoplastic reaction; Myofibroblast; Smooth muscle actin

Indexed keywords

ALPHA ACTIN; BETA GALACTOSIDE; CD31 ANTIGEN; DNA TOPOISOMERASE (ATP HYDROLYSING); RAG1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DERIVATIZATION; ENDOTHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IRRADIATION; MOUSE; MUTANT; MYOFIBROBLAST; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECIPIENT; SCID MOUSE; TRANSGENIC MOUSE; XENOTRANSPLANTATION;

EID: 0041441245     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01544-4     Document Type: Article

References (36)

1. Plate J.M., Harris J.E. Immune cell functions in pancreatic cancer. Semin. Oncol. 29:2002;27-30.
2. Folkman J., Hahnfeldt P., Hlatky L. Cancer: looking outside the genome. Nat. Rev. Mol. Cell Biol. 1:2000;76-79.
3. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 14:2000;249-257.
4. Jelaska A., Strehlow D., Korn J.H. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin. Immunopathol. 21:1999;385-395.
5. Ronnov-Jessen L., van Deurs B., Celis J.E., Petersen O.W. Smooth muscle differentiation in cultured human breast gland stromal cells. Lab. Invest. 63:1990;532-543.
6. Hasebe T., Imoto S., Ogura T., Mukai K. Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am. J. Pathol. 156:2000;1701-1710.
7. Hasebe T., Sasaki S., Imoto S., Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod. Pathol. 14:2001;325-337.
8. Okusa Y., Ichikura T., Mochizuki H. Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer. 85:1999;1033-1038.
9. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 27:2000;481-490.
10. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 19-26:2002;860-867.
11. Garrett D.M., Conrad G.W. Fibroblast-like cells from embryonic chick cornea, heart, and skin are antigenically distinct. Dev. Biol. 70:1979;50-70.
12. Schor S.L., Schor A.M. Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. Bioessays. 7:1987;200-204.
13. Alvarez R.J., Sun M.J., Haverty T.P., Iozzo R.V., Myers J.C., Neilson E.G. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int. 41:1992;14-23.
14. Ronnov-Jessen L., Van Deurs B., Nielsen M., Petersen O.W. Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev. Biol. 28A:1992;273-283.
15. Ronnov-Jessen L., Petersen O.W., Koteliansky V.E., Bissell M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95:1995;859-873.
16. Dugina V., Alexandrova A., Chaponnier C., Vasiliev J., Gabbiani G. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp. Cell Res. 238:1998;481-490.
17. Petersen O.W., Nielsen H.L., Gudjonsson T., Villadsen R., Rank F., Niebuhr E., Bissell M.J., Ronnov-Jessen L. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162:2003;391-402.
18. Zambrowicz B.P., Imamoto A., Fiering S., Herzenberg L.A., Kerr W.G., Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. USA. 94:1997;3789-3794.
19. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68:1992;869-877.
20. Tam P.P., Parameswaran M., Kinder S.J., Weinberger R.P. The allocation of epiblast cells to the embryonic heart and other mesodermal lineages: the role of ingression and tissue movement during gastrulation. Development. 124:1997;1631-1642.
21. Kunz-Schughart L.A., Heyder P., Schroeder J., Knuechel R. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp. Cell Res. 266:2001;74-86.
22. Takahashi G.W., Moran D., Andrews III D.F., Singer J.W. Differential expression of collagenase by human fibroblasts and bone marrow stromal cells. Leukemia. 8:1994;305-308.
23. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S.A., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:2002;41-49.
24. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:1997;71-74.
25. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 153:2001;1133-1140.
26. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:2001;1194-1201.
27. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:1999;697-705.
28. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:2002;341-350.
29. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 62:2002;3603-3608.
30. Emura M., Ochiai A., Horino M., Arndt W., Kamino K., Hirohashi S. Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev. Biol. Anim. 36:2000;77-80.
31. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1:1994;71-81.
32. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166:2001;7556-7562.
33. Chesney J., Metz C., Stavitsky A.B., Bacher M., Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160:1998;419-425.
34. Blazar B.R., Taylor Brittan M., McElmurry R., Tian L., Panoskaltsis-Mortari A., Lam S., Lees C., Waldschmidt T., Vallera D.A. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood. 92:1998;3949-3959.
35. Bilimoria M.M., Lauwers G.Y., Doherty D.A., Nagorney D.M., Belghiti J., Do K.A., Regimbeau J.M., Ellis L.M., Curley S.A., Ikai I., Yamaoka Y., Vauthey J.N. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch. Surg. 136:2001;528-535.
36. Bissell M.J., Radisky D. Putting tumours in context. Nat. Rev. Cancer. 1:2001;46-54.